22 USC § 7653 - Annual reports on prevention of mother-to-child transmission of the HIV infection

---
identifier: "/us/usc/t22/s7653"
source: "usc"
legal_status: "official_prima_facie"
title: "22 USC § 7653 - Annual reports on prevention of mother-to-child transmission of the HIV infection"
title_number: 22
title_name: "FOREIGN RELATIONS AND INTERCOURSE"
section_number: "7653"
section_name: "Annual reports on prevention of mother-to-child transmission of the HIV infection"
chapter_number: 83
chapter_name: "UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA"
subchapter_number: "III"
subchapter_name: "BILATERAL EFFORTS"
part_number: "B"
part_name: "Assistance for Women, Children, and Families"
positive_law: false
currency: "119-84"
last_updated: "2026-03-26"
format_version: "1.1.0"
generator: "[email protected]"
source_credit: "(Pub. L. 108–25, title III, § 313, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, § 308, July 30, 2008, 122 Stat. 2964.)"
---


# § 7653. Annual reports on prevention of mother-to-child transmission of the HIV infection

**(a)** **In general** May 27, 2003

Not later than 1 year after , and annually thereafter for a period of 10 years, the President shall submit to appropriate congressional committees a report on the activities of relevant executive branch agencies during the reporting period to assist in the prevention of mother-to-child transmission of the HIV infection.

**(b)** **Report elements** Each report shall include—

**(1)** a statement of whether or not all relevant executive branch agencies have met the goal described in section 7652(b)(1) of this title; and

**(2)** a description of efforts made by the relevant executive branch agencies to expand those activities, including—

**(A)** information on the number of sites supported for the prevention of mother-to-child transmission of the HIV infection;

**(B)** the specific activities supported;

**(C)** the number of women tested and counseled; and

**(D)** the number of women receiving preventative drug therapies.

**(c)** **Reporting period defined** May 27, 2003

In this section, the term “reporting period” means, in the case of the initial report, the period since , and, in the case of any subsequent report, the period since the date of submission of the most recent report.

---

**Source Credit**: (Pub. L. 108–25, title III, § 313, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, § 308, July 30, 2008, 122 Stat. 2964.)

## Editorial Notes

### Amendments

2008—Subsec. (a).  substituted “10 years” for “5 years”.

## Executive Documents

### Delegation of Functions

For delegation of functions of President under this section, see Ex. Ord. No. 12163, , 44 F.R. 56673, as amended, set out as a note under , and Memorandum of President of , 69 F.R. 9509, set out as a note under .